Public health officials and private researchers have vowed to develop a coronavirus vaccine in record time. But could that rush backfire? Guest: Jan Hoffman, a health reporter for The New York Times. For more information on today’s episode, visit nytimes.com/thedaily
Background reading: Billions of dollars are being poured into developing a coronavirus vac ... Show More
Yesterday
More Trump Tariffs Are Coming
At a moment when inflation and affordability are on virtually everyone’s mind in America, Jamieson Greer, the U.S. trade representative, said the Trump administration was planning a new slate of tariffs. Ana Swanson, who covers international trade for The New York Times and spoke ... Show More
40m 27s
Dec 2020
Vaccine hesitancy, the next pandemic hurdle
As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy.
Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ... Show More
31m 47s
Jul 2020
Why a Vaccine Won't Create Instant Immunity
An effective vaccine is seen as the world’s greatest hope for achieving some kind of return to normal, and the timeline for developing one has been sped up dramatically. But as hard as it’s going to be to make a vaccine quickly, once we do, we’ll have a new problem: Getting it to ... Show More
12m 36s